Porcine Vaccines
SKU
MRR-742BD5183CF6
Region
Global
Publication Date
January 2024
Delivery
Immediate
2022
USD 1.61 billion
2030
USD 2.70 billion
2023
USD 1.71 billion
CAGR
6.65%
Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2023-2030

[184 Pages Report] The Porcine Vaccines Market size was estimated at USD 1.61 billion in 2022 and expected to reach USD 1.71 billion in 2023, at a CAGR 6.65% to reach USD 2.70 billion by 2030.

Porcine Vaccines Market
To learn more about this report, request a free sample copy

Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. These vaccines are created to stimulate the porcine immune system, enabling it to develop defenses against pathogens such as viruses or bacteria that can cause illness. By mimicking the infection, they prepare the swine’s body to recognize and combat the actual pathogens should they be encountered in the future. The rise in the incidence of swine diseases and the growing global consumption of pork products are major driving factors behind the need for porcine vaccines. Furthermore, supportive government initiatives, including subsidies and awareness programs, have encouraged the use of vaccines. However, the need for a cold chain infrastructure creates logistical challenges, particularly in developing countries. Furthermore, the variability in the immune response of different pig breeds can impact vaccine effectiveness and create hurdles for the development and adoption of porcine vaccines. However, key players are exploring novel technologies such as nanotechnology, gene editing strategies, and precision medicine to ensure the development of customized vaccines that can overcome the performance challenges of porcine vaccines. Moreover, investigating new adjuvants to enhance immune response without compromising safety and developing needle-free administration could improve vaccine uptake and reduce stress on animals.

Porcine Vaccines Market - Global Forecast 2023-2030
To learn more about this report, request a free sample copy
Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies

A conjugate vaccine refers to a vaccine that is composed of a polysaccharide antigen fused or conjugated to a carrier molecule. In porcine vaccines, they are used to target diseases where the pathogens have polysaccharide coatings, which are generally poorly immunogenic. Such vaccines are especially useful for targeting diseases caused by bacteria with polysaccharide capsules. DNA vaccines utilize genetic material to induce an immune response. When the genetic material enters the animal's cells, it is used to produce the antigen which in turn stimulates the immune system. These vaccines are still relatively novel in the veterinary field. Such vaccines may be preferred for their potential for rapid development and their ability to provide long-lasting immunity without the need for adjuvants. Inactivated vaccines contain pathogens that have been killed. They cannot cause an infection but still prompt an immune response. These vaccines are considered safe and stable. Live attenuated vaccines contain a live and weakened version of the pathogen. They closely mimic a natural infection and typically provide strong, long-lasting immunity. Recombinant vaccines use a piece of the pathogen (typically a protein) created using the techniques of genetic engineering. This component is used to stimulate an immune response without the risk of introducing a live pathogen. Toxoid vaccines are created by inactivating the toxins produced by certain bacteria. These vaccines are used to protect against diseases that are caused not by the bacteria itself, but by the toxins they produce. Toxoid vaccines are the preferred option when addressing illnesses where the primary concern is the bacterial toxin.

End User: Growing need for mass vaccination programs in the hog/pig production farm

The hog/pig production farm sector includes entities involved in raising pigs primarily for meat production. The need for vaccines in such farms is driven by the requirement to maintain a disease-free environment, enhance growth performance of the animals, and ultimately increase farmer profitability. Hog and pig production farms typically require vaccines thar can address a wide spectrum of common swine diseases, such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and foot and mouth disease, among others. Veterinary clinics and hospitals cater to a broad range of animals, including pigs. These facilities generally encounter pigs and other swine for vaccinations as part of routine health checks or specific disease outbreaks. The vaccine preferences in this environment are for products with broad-spectrum efficacy and rapid onset of immunity. Since these facilities might be dealing with individual animals or small herds, they often prefer single-dose, easy-to-administer vaccines that are also available in smaller package sizes.

Regional Insights

In the Americas region, particularly the U.S. and Canada, the porcine vaccine market is well-established due to the extensive pig farming industry and a strong emphasis on animal health management. The country sees a significant consumer need for vaccinations against prevalent diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and others. Producers often adopt the latest vaccines, and purchasing behavior indicates a readiness to invest in advanced solutions for swine herds. Recent research in the U.S. has focused on developing vaccines with improved efficacy and longer immunity periods. Investments in biotechnology companies and government initiatives such as the Veterinary Biologics Program under the United States Department of Agriculture(USDA)-Animal & Plant Health Inspection Service(APHIS) reflect ongoing efforts to strengthen the sector. The EMEA countries represent a diverse market with stringent animal welfare and health regulations. The European consumer requires vaccines that comply with high safety standards, leading to a demand for quality-assured vaccines. The EU’s Horizon 2020 program has seen substantial investments in research addressing swine diseases, which propels the development of new and efficient vaccines. In the APAC region, China represents a highly evolved market for pig meat, thereby accentuating the need for porcine markets. India, with an emerging pig farming industry in the APAC region, presents a moderate but growing demand for porcine vaccines. Consumer needs revolve around affordable and accessible vaccines due to cost-sensitive purchasing behaviors. The government has been encouraging the growth of the swine industry through initiatives that provide support for vaccinations and animal health programs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Porcine Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Porcine Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Zoetis Launches Circomax In The UK

    Zoetis has introduced CircoMax to the UK market, a vaccine designed to combat porcine circovirus type 2 (PCV2). This vaccine is formulated to target multiple strains of the virus, offering protection against genotypes PCV2a, PCV2b, and PCV2d. These genotypes represent the primary variants found within the UK’s pig population. The relevance of CircoMax is cemented by current research indicating a shift in the dominant genotypes over time, from PCV2a originally to PCV2b, and most recently to PCV2d, highlighting the dynamic nature of the virus. [Published On: 2023-10-13]

  • Merck Animal Health Launches 3-In-One Swine Vaccine

    Merck Animal Health announced the launch of Circumvent CML, a novel trivalent swine vaccine designed to combat key porcine diseases. Circumvent CML marks a significant advancement in swine health, delivering protection against porcine circovirus Type 2a (PCV-2a), porcine circovirus type 2d (PCV-2d), mycoplasma hyopneumoniae, and lawsonia intracellularis in one comprehensive formulation. This innovative vaccine encapsulates the effectiveness of Merck's established antigens and adjuvant systems, previously demonstrated in products such as Circumvent PCV-M G2 and Porcilis Ileitis, providing an integrated solution for swine producers. [Published On: 2023-06-14]

  • Elanco is Exclusive U.S. Distributor of Aptimmune’s PRRS Killed Autogenous Vaccine

    Elanco Animal Health Incorporated has secured an exclusive distribution agreement with Aptimmune Biologics, Inc. This arrangement positions Elanco as the sole provider of a novel porcine reproductive and respiratory syndrome (PRRS) vaccine, leveraging Aptimmune's innovative Barricade formula. This inactivated vaccine would complement Elanco's existing Prevacent PRRS live vaccine, thereby enhancing their portfolio of respiratory illness interventions. [Published On: 2023-05-13]

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Arko Laboratories, AVAC Vietnam Joint Stock Company, Bayer AG, Bimeda Holdings PLC, Biogénesis Bagó S.A., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Endovac Animal Health, FATRO S.p.A., Formosa Biomedical Inc., Genvax Technologies, Inc., HIPRA, S.A., Indian Immunologicals Ltd., KM Biologics Co., Ltd., Kyoto Biken Laboratories, Inc., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Medgene Labs, Merck & Co., Inc., Nisseiken Co., Ltd., PBS Animal Health, Phibro Animal Health Corporation, Virbac SA, Yenher Agro-Products Sdn. Bhd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Porcine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Arthritis
    • Diarrhea
    • Porcine Circovirus Associated Disease
    • Porcine Reproductive & Respiratory Syndrome
    • Swine Influenza
  • Technology
    • Conjugate Vaccines
    • DNA Vaccines
    • Inactivated Vaccines
    • Live attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • End User
    • Hog/Pig Production Farm
    • Veterinary Clinics/Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Porcine Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Porcine Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Porcine Vaccines Market?
  4. What is the market share of the leading vendors in the Porcine Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Porcine Vaccines Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoveragePORCINE VACCINES MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. PORCINE VACCINES MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. PORCINE VACCINES MARKET SIZE, 2022 VS 2030
  4. Market Overview
    1. IntroductionPORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
    2. Porcine Vaccines Market, by RegionPORCINE VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)PORCINE VACCINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsPORCINE VACCINES MARKET DYNAMICS
      1. Drivers
        1. Rise in Prevalence of Swine Diseases Worldwide
        2. Increasing Demand for High-Quality Pork Meat
        3. Government Initiatives to Support Animal Health
      2. Restraints
        1. High Cost of Porcine Vaccine Development and Complex Storage Issues
      3. Opportunities
        1. Technological Advancements in Porcine Vaccine
        2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
      4. Challenges
        1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
    2. Market Segmentation Analysis
      1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
      2. End User: Growing need for mass vaccination programs in the hog/pig production farm
    3. Market Trend Analysis
    4. Cumulative Impact of COVID-19
    5. Cumulative Impact of Russia-Ukraine Conflict
    6. Cumulative Impact of High Inflation
    7. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    8. Value Chain & Critical Path Analysis
    9. Regulatory Framework
    10. Client Customization
  6. Porcine Vaccines Market, by Indication
    1. IntroductionPORCINE VACCINES MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)PORCINE VACCINES MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
    2. ArthritisPORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY , 2018-2030 (USD MILLION)
    3. DiarrheaPORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY , 2018-2030 (USD MILLION)
    4. Porcine Circovirus Associated DiseasePORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY , 2018-2030 (USD MILLION)
    5. Porcine Reproductive & Respiratory SyndromePORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY , 2018-2030 (USD MILLION)
    6. Swine InfluenzaPORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY , 2018-2030 (USD MILLION)
  7. Porcine Vaccines Market, by Technology
    1. IntroductionPORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
    2. Conjugate VaccinesPORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY , 2018-2030 (USD MILLION)
    3. DNA VaccinesPORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY , 2018-2030 (USD MILLION)
    4. Inactivated VaccinesPORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY , 2018-2030 (USD MILLION)
    5. Live attenuated VaccinesPORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY , 2018-2030 (USD MILLION)
    6. Recombinant VaccinesPORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY , 2018-2030 (USD MILLION)
    7. Toxoid VaccinesPORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY , 2018-2030 (USD MILLION)
  8. Porcine Vaccines Market, by End User
    1. IntroductionPORCINE VACCINES MARKET SIZE, BY END USER, 2022 VS 2030 (%)PORCINE VACCINES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    2. Hog/Pig Production FarmPORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY , 2018-2030 (USD MILLION)
    3. Veterinary Clinics/HospitalsPORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY , 2018-2030 (USD MILLION)
  9. Americas Porcine Vaccines Market
    1. Introduction
    2. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Porcine Vaccines Market
    1. Introduction
    2. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Porcine Vaccines Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixPORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2022PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
    2. Market Share Analysis, By Key PlayerPORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2022PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2022
    3. Competitive Scenario Analysis, By Key Player
      1. Zoetis Launches Circomax In The UK
      2. Merck Animal Health Launches 3-In-One Swine Vaccine
      3. Elanco is Exclusive U.S. Distributor of Aptimmune’s PRRS Killed Autogenous Vaccine
  13. Competitive Portfolio
    1. Key Company Profiles
      1. Aptimmune Biologics, Inc.
      2. Arko Laboratories
      3. AVAC Vietnam Joint Stock Company
      4. Bayer AG
      5. Bimeda Holdings PLC
      6. Biogénesis Bagó S.A.
      7. Boehringer Ingelheim International GmbH
      8. Ceva Sante Animale
      9. Eli Lilly and Company
      10. Endovac Animal Health
      11. FATRO S.p.A.
      12. Formosa Biomedical Inc.
      13. Genvax Technologies, Inc.
      14. HIPRA, S.A.
      15. Indian Immunologicals Ltd.
      16. KM Biologics Co., Ltd.
      17. Kyoto Biken Laboratories, Inc.
      18. Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
      19. Medgene Labs
      20. Merck & Co., Inc.
      21. Nisseiken Co., Ltd.
      22. PBS Animal Health
      23. Phibro Animal Health Corporation
      24. Virbac SA
      25. Yenher Agro-Products Sdn. Bhd.
      26. Zoetis Inc.
    2. Key Product Portfolio
  1. Aptimmune Biologics, Inc.
  2. Arko Laboratories
  3. AVAC Vietnam Joint Stock Company
  4. Bayer AG
  5. Bimeda Holdings PLC
  6. Biogénesis Bagó S.A.
  7. Boehringer Ingelheim International GmbH
  8. Ceva Sante Animale
  9. Eli Lilly and Company
  10. Endovac Animal Health
  11. FATRO S.p.A.
  12. Formosa Biomedical Inc.
  13. Genvax Technologies, Inc.
  14. HIPRA, S.A.
  15. Indian Immunologicals Ltd.
  16. KM Biologics Co., Ltd.
  17. Kyoto Biken Laboratories, Inc.
  18. Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
  19. Medgene Labs
  20. Merck & Co., Inc.
  21. Nisseiken Co., Ltd.
  22. PBS Animal Health
  23. Phibro Animal Health Corporation
  24. Virbac SA
  25. Yenher Agro-Products Sdn. Bhd.
  26. Zoetis Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Porcine Vaccines Market
The Global Porcine Vaccines Market size was estimated at USD 1.61 billion in 2022 and expected to reach USD 1.71 billion in 2023.
The Global Porcine Vaccines Market to grow USD 2.70 billion by 2030, at a CAGR of 6.65%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.